Prelude Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $6,500 | $0 | $0 | $4,000 |
Gross Profit | 6,075 | -433 | -435 | 4,000 |
EBITDA | -19,300 | -31,761 | -34,171 | -33,342 |
EBIT | -19,725 | -32,194 | -34,606 | -33,831 |
Net Income | -19,725 | -31,231 | -32,085 | -28,731 |
Net Change In Cash | 6,500 | 0 | 0 | 4,000 |
Free Cash Flow | -19,115 | -26,095 | -34,278 | -20,797 |
Cash | 47,532 | 25,752 | 40,269 | 12,474 |
Basic Shares | 76,132 | 75,993 | 75,986 | 75,896 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $7,000 | $0 | $0 | $0 |
Gross Profit | 7,000 | -1,169 | -3,042 | -2,243 |
EBITDA | -137,942 | -131,108 | -122,216 | -112,820 |
EBIT | -139,714 | -132,276 | -123,540 | -113,735 |
Net Income | -127,173 | -121,832 | -107,336 | -110,779 |
Net Change In Cash | 7,000 | 0 | 0 | 0 |
Free Cash Flow | -103,652 | -110,576 | -86,748 | -85,854 |
Cash | 12,474 | 25,291 | 30,605 | 31,828 |
Basic Shares | 75,805 | 60,357 | 47,371 | 47,602 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.26 |
2025-06-30 | -$0.41 |
2025-03-31 | -$0.42 |
